Receptors, Antigen

DBCAT004651Pharmacologic class

Molecules on the surface of B- and T-lymphocytes that recognize and combine with specific antigens. A DrugBank category of 4 drugs. 3 of them are approved.

Drugs: ALT-801
Brexucabtagene autoleucel
Idecabtagene vicleucel
Tisagenlecleucel

What you can answer from here — as of May 21, 2019

4DrugsEach linked to its full drug card

Listed above

7Drug targetsEvery drug–target pair in the class, with bond type

13Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Receptors, Antigen share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account